Clinical Trial Update: 12-h and 2-h Urokinase Regimes of Pulmonary Thromboembolism in China [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing 12-hour and 2-hour urokinase regimens for pulmonary embolism in China has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Embolism
• Venous Thromboembolism

Drugs mentioned

• Urokinase (urokinase)

Snippet

Sponsor: Beijing Chao Yang Hospital | Conditions: Pulmonary Embolism, Thromboembolism | Phase 4 | Status: COMPLETED